Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy
Multiple small studies of oral n-acetylcysteine for prevention of contrast nephropathy have been performed, demonstrating variable efficacy. We performed a meta-analysis of the randomized clinical trials to clarify the degree of benefit.
Gespeichert in:
| Veröffentlicht in: | The American journal of cardiology 2003-12, Vol.92 (12), p.1454-1458 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1458 |
|---|---|
| container_issue | 12 |
| container_start_page | 1454 |
| container_title | The American journal of cardiology |
| container_volume | 92 |
| creator | Isenbarger, Daniel W. Kent, Steven M. O'Malley, Patrick G. |
| description | Multiple small studies of oral n-acetylcysteine for prevention of contrast nephropathy have been performed, demonstrating variable efficacy. We performed a meta-analysis of the randomized clinical trials to clarify the degree of benefit. |
| doi_str_mv | 10.1016/j.amjcard.2003.08.059 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_230367808</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914903012852</els_id><sourcerecordid>550820801</sourcerecordid><originalsourceid>FETCH-LOGICAL-e320t-a3cef4a78aefb5c4f9f73706469b9012c872c0e61033b1a3060e2dba9948b00e3</originalsourceid><addsrcrecordid>eNpF0dGK1TAQBuAgint29RGUIHjZOmnaNLkSWdQVVrzR65CmE05KT1qT9ED36c26R7wKQz4G5v8JecOgZsDEh6k2p8maONYNAK9B1tCpZ-TAZK8qphh_Tg4A0FSKteqKXKc0lZGxTrwkV6wVfddJcSDn75hNZYKZ9-QTXRyNJozLyT_gSO3sg7dmpjl6M5ffQPMR6ZbQbXPA9Ncbi3mf7Z4y-oDULZGuEc8Ysi--ALuEHE3KNOB6jMtq8nF_RV64shFfX94b8uvL55-3d9X9j6_fbj_dV8gbyJXhFl1remnQDZ1tnXI970G0Qg0KWGNl31hAwYDzgRkOArAZB6NUKwcA5Dfk3dPeNS6_N0xZT8sWy7VJNxy46CXIgt5e0DaccNRr9CcTd_0vpQLeX4BJJQ5XIrI-_XcdF5x3vLiPTw7LSWePUSfrMVgcfUSb9bh4zUA_9qcnfelPP_anQerSH_8DS-CQkQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230367808</pqid></control><display><type>article</type><title>Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Isenbarger, Daniel W. ; Kent, Steven M. ; O'Malley, Patrick G.</creator><creatorcontrib>Isenbarger, Daniel W. ; Kent, Steven M. ; O'Malley, Patrick G.</creatorcontrib><description>Multiple small studies of oral n-acetylcysteine for prevention of contrast nephropathy have been performed, demonstrating variable efficacy. We performed a meta-analysis of the randomized clinical trials to clarify the degree of benefit.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2003.08.059</identifier><identifier>PMID: 14675586</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Acetylcysteine - therapeutic use ; Acute Kidney Injury - chemically induced ; Acute Kidney Injury - prevention & control ; Analysis ; Antioxidants - therapeutic use ; Biological and medical sciences ; Cardiovascular disease ; Clinical trials ; Contrast Media - adverse effects ; Creatinine - blood ; General and cellular metabolism. Vitamins ; Humans ; Medical sciences ; Pharmacology. Drug treatments ; Prevention ; Randomized Controlled Trials as Topic</subject><ispartof>The American journal of cardiology, 2003-12, Vol.92 (12), p.1454-1458</ispartof><rights>2003 Excerpta Medica Inc.</rights><rights>2004 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. Dec 15, 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.amjcard.2003.08.059$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15363353$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14675586$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Isenbarger, Daniel W.</creatorcontrib><creatorcontrib>Kent, Steven M.</creatorcontrib><creatorcontrib>O'Malley, Patrick G.</creatorcontrib><title>Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Multiple small studies of oral n-acetylcysteine for prevention of contrast nephropathy have been performed, demonstrating variable efficacy. We performed a meta-analysis of the randomized clinical trials to clarify the degree of benefit.</description><subject>Acetylcysteine - therapeutic use</subject><subject>Acute Kidney Injury - chemically induced</subject><subject>Acute Kidney Injury - prevention & control</subject><subject>Analysis</subject><subject>Antioxidants - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular disease</subject><subject>Clinical trials</subject><subject>Contrast Media - adverse effects</subject><subject>Creatinine - blood</subject><subject>General and cellular metabolism. Vitamins</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Prevention</subject><subject>Randomized Controlled Trials as Topic</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpF0dGK1TAQBuAgint29RGUIHjZOmnaNLkSWdQVVrzR65CmE05KT1qT9ED36c26R7wKQz4G5v8JecOgZsDEh6k2p8maONYNAK9B1tCpZ-TAZK8qphh_Tg4A0FSKteqKXKc0lZGxTrwkV6wVfddJcSDn75hNZYKZ9-QTXRyNJozLyT_gSO3sg7dmpjl6M5ffQPMR6ZbQbXPA9Ncbi3mf7Z4y-oDULZGuEc8Ysi--ALuEHE3KNOB6jMtq8nF_RV64shFfX94b8uvL55-3d9X9j6_fbj_dV8gbyJXhFl1remnQDZ1tnXI970G0Qg0KWGNl31hAwYDzgRkOArAZB6NUKwcA5Dfk3dPeNS6_N0xZT8sWy7VJNxy46CXIgt5e0DaccNRr9CcTd_0vpQLeX4BJJQ5XIrI-_XcdF5x3vLiPTw7LSWePUSfrMVgcfUSb9bh4zUA_9qcnfelPP_anQerSH_8DS-CQkQ</recordid><startdate>20031215</startdate><enddate>20031215</enddate><creator>Isenbarger, Daniel W.</creator><creator>Kent, Steven M.</creator><creator>O'Malley, Patrick G.</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7TS</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope></search><sort><creationdate>20031215</creationdate><title>Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy</title><author>Isenbarger, Daniel W. ; Kent, Steven M. ; O'Malley, Patrick G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e320t-a3cef4a78aefb5c4f9f73706469b9012c872c0e61033b1a3060e2dba9948b00e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Acetylcysteine - therapeutic use</topic><topic>Acute Kidney Injury - chemically induced</topic><topic>Acute Kidney Injury - prevention & control</topic><topic>Analysis</topic><topic>Antioxidants - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular disease</topic><topic>Clinical trials</topic><topic>Contrast Media - adverse effects</topic><topic>Creatinine - blood</topic><topic>General and cellular metabolism. Vitamins</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Prevention</topic><topic>Randomized Controlled Trials as Topic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Isenbarger, Daniel W.</creatorcontrib><creatorcontrib>Kent, Steven M.</creatorcontrib><creatorcontrib>O'Malley, Patrick G.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Isenbarger, Daniel W.</au><au>Kent, Steven M.</au><au>O'Malley, Patrick G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2003-12-15</date><risdate>2003</risdate><volume>92</volume><issue>12</issue><spage>1454</spage><epage>1458</epage><pages>1454-1458</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>Multiple small studies of oral n-acetylcysteine for prevention of contrast nephropathy have been performed, demonstrating variable efficacy. We performed a meta-analysis of the randomized clinical trials to clarify the degree of benefit.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>14675586</pmid><doi>10.1016/j.amjcard.2003.08.059</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9149 |
| ispartof | The American journal of cardiology, 2003-12, Vol.92 (12), p.1454-1458 |
| issn | 0002-9149 1879-1913 |
| language | eng |
| recordid | cdi_proquest_journals_230367808 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Acetylcysteine - therapeutic use Acute Kidney Injury - chemically induced Acute Kidney Injury - prevention & control Analysis Antioxidants - therapeutic use Biological and medical sciences Cardiovascular disease Clinical trials Contrast Media - adverse effects Creatinine - blood General and cellular metabolism. Vitamins Humans Medical sciences Pharmacology. Drug treatments Prevention Randomized Controlled Trials as Topic |
| title | Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T19%3A01%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Meta-analysis%20of%20randomized%20clinical%20trials%20on%20the%20usefulness%20of%20acetylcysteine%20for%20prevention%20of%20contrast%20nephropathy&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Isenbarger,%20Daniel%20W.&rft.date=2003-12-15&rft.volume=92&rft.issue=12&rft.spage=1454&rft.epage=1458&rft.pages=1454-1458&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2003.08.059&rft_dat=%3Cproquest_pubme%3E550820801%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=230367808&rft_id=info:pmid/14675586&rft_els_id=S0002914903012852&rfr_iscdi=true |